These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 205786)
81. Erythrocyte transketolase activity in uremia. Kuriyama M; Mizuma A; Yokomine R; Igata A; Otuji Y Clin Chim Acta; 1980 Dec; 108(2):169-77. PubMed ID: 6256098 [TBL] [Abstract][Full Text] [Related]
82. Does hypermagnesemia suppress parathyroid activity and therefore play a role in amelioration of uremic toxicity? Oe PL; van der Meulen J; Lips PT; de Vries PM; van Bronswijk H; Donker AJ Adv Exp Med Biol; 1987; 223():149-52. PubMed ID: 3447431 [No Abstract] [Full Text] [Related]
83. Is pruritus in chronic uremic patients related to peripheral somatic and autonomic neuropathy? Study by R-R interval variation test (RRIV) and by sympathetic skin response (SSR). Zakrzewska-Pniewska B; Jedras M Neurophysiol Clin; 2001 Jun; 31(3):181-93. PubMed ID: 11488229 [TBL] [Abstract][Full Text] [Related]
87. Detection of uremic neuropathy by reflex response latency. Knoll O; Dierker E J Neurol Sci; 1980 Aug; 47(2):305-12. PubMed ID: 6251176 [TBL] [Abstract][Full Text] [Related]
88. Famotidine reduces serum parathyroid hormone levels in uremic patients. Arik N; Arinsoy T; Sayín M; Taşdemir I; Yasavul U; Turgan C; Caglar S Nephron; 1991; 59(2):333. PubMed ID: 1956503 [No Abstract] [Full Text] [Related]
89. Normal and pathologic concentrations of uremic toxins. Duranton F; Cohen G; De Smet R; Rodriguez M; Jankowski J; Vanholder R; Argiles A; J Am Soc Nephrol; 2012 Jul; 23(7):1258-70. PubMed ID: 22626821 [TBL] [Abstract][Full Text] [Related]
90. Assessment of the characteristics and quality of life of patients with uremic peripheral neuropathy . Yu XZ; Lu S; Gou W; Wang W; Zou SH; Han YX; Wang WW; Zhang JY Clin Nephrol; 2017 Mar; 87 (2017)(3):134-139. PubMed ID: 28102815 [TBL] [Abstract][Full Text] [Related]
91. H reflexes as a measure for uremic polyneuropathy. A longitudinal study in patients treated with dialysis or renal transplantation. De Weerd AW; Nihom J; Rozeman CA; Poortvliet DC; Jonkman EJ; Van der Maas AP; Tjandra YI Electroencephalogr Clin Neurophysiol; 1994 Aug; 93(4):276-80. PubMed ID: 7521287 [TBL] [Abstract][Full Text] [Related]
93. Relationship of nervous tissue transketolase to the neuropathy in chronic uremia. Sterzel RB; Semar M; Lonergan ET; Treser G; Lange K J Clin Invest; 1971 Nov; 50(11):2295-304. PubMed ID: 5096513 [TBL] [Abstract][Full Text] [Related]
94. Peripheral motor nerve conduction velocities in children undergoing chronic hemodialysis. Mentser MI; Clay S; Malekzadeh MH; Pennisi AJ; Ettenger RB; Uittenbogaart CH; Fine RN Nephron; 1978; 22(4-6):337-41. PubMed ID: 216941 [TBL] [Abstract][Full Text] [Related]
95. Is parathyroid hormone a uremic toxin? Massry SG Nephron; 1977; 19(3):125-30. PubMed ID: 895963 [No Abstract] [Full Text] [Related]
96. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Kuwabara S; Nakazawa R; Azuma N; Suzuki M; Miyajima K; Fukutake T; Hattori T Intern Med; 1999 Jun; 38(6):472-5. PubMed ID: 10411351 [TBL] [Abstract][Full Text] [Related]
98. Role of parathyroid hormone in the pathogenesis of the uremic manifestations. Massry SG Klin Wochenschr; 1979 Oct; 57(19):1085-8. PubMed ID: 392183 [TBL] [Abstract][Full Text] [Related]
99. On the pathogenesis of the uremic state--an exposition of the trade-off hypothesis. Bricker NS Nihon Jinzo Gakkai Shi; 1974 Apr; 16(4):327-39. PubMed ID: 4474520 [No Abstract] [Full Text] [Related]
100. Electrophysiological course of uraemic neuropathy in haemodialysis patients. Ogura T; Makinodan A; Kubo T; Hayashida T; Hirasawa Y Postgrad Med J; 2001 Jul; 77(909):451-4. PubMed ID: 11423596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]